 | | PRD_000185 | | Name: | SURFACTIN nC15 | | Formula: | C52 H91 N7 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000561 | | Name: | FR901277 | | Formula: | C47 H63 N9 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002187 | | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-23-oxa-6,9,14,21,22-pentaazabicyclo[18.2.1]tricosa-1(22),20-dien-4-yl]carbamate | | Formula: | C30 H50 N6 O7 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_002189 | | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-22-oxa-6,9,14,20,21-pentaazabicyclo[17.2.1]docosa-1(21),19-dien-4-yl]carbamate | | Formula: | C29 H48 N6 O7 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_002250 | | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | | Formula: | C32 H40 N4 O5 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002252 | | Name: | N,N-diethyl-N~2~-[(2E)-3-phenylprop-2-enoyl]-L-asparaginyl-4-fluoro-N-[(naphthalen-1-yl)methyl]-L-phenylalaninamide | | Formula: | C37 H39 F N4 O4 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002255 | | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | | Formula: | C31 H38 N4 O4 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002272 | | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | | Formula: | C25 H44 N14 O7 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_002289 | | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | | Formula: | C68 H85 N13 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002290 | | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | | Formula: | C69 H90 N13 O12 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002295 | | Formula: | C89 H131 N23 O25 S3 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_000734 | | Name: | ALL-D KALATA B1 | | Formula: | C117 H180 N35 O39 S6 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000749 | | Name: | KALATA B1 | | Formula: | C117 H180 N35 O39 S6 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000752 | | Name: | CIRCULIN A | | Formula: | C134 H211 N38 O38 S6 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002363 | | Formula: | C73 H120 N20 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002365 | | Name: | phazolicin | | Formula: | C74 H104 N29 O27 S3 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_900129 | | Name: | Lewis A antigen, beta anomer | | Formula: | C20 H35 N O15 | | Description: | oligosaccharide with branches | | Definition date: | 2020-08-05 | | Last modified: | 2020-08-05 |
|
 | | PRD_900130 | | Name: | Lewis A antigen, alpha anomer | | Formula: | C20 H35 N O15 | | Description: | oligosaccharide with branches | | Definition date: | 2020-08-05 | | Last modified: | 2020-08-05 |
|
 | | PRD_900131 | | Name: | Blood group A H type 1 antigen, beta anomer | | Formula: | C28 H48 N2 O20 | | Description: | oligosaccharide with branches | | Definition date: | 2020-08-05 | | Last modified: | 2020-08-05 |
|
 | | PRD_900132 | | Name: | Blood group A H type 2 antigen, beta anomer | | Formula: | C28 H48 N2 O20 | | Description: | oligosaccharide with branches | | Definition date: | 2020-08-05 | | Last modified: | 2020-08-05 |
|
 | | PRD_900133 | | Name: | Blood group A H type 2 antigen, alpha anomer | | Formula: | C28 H48 N2 O20 | | Description: | oligosaccharide with branches | | Definition date: | 2020-08-05 | | Last modified: | 2020-08-05 |
|
 | | PRD_900001 | | Name: | MALTOSE | | Formula: | C12 H22 O11 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900002 | | Name: | raffinose | | Formula: | C18 H32 O16 | | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900003 | | Name: | SUCROSE | | Formula: | C12 H22 O11 | | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900004 | | Name: | BETA-LACTOSE | | Formula: | C12 H22 O11 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
